From the Guidelines
The waiting period after enoxaparin administration before an epidural can be safely performed is at least 12 hours.
Key Considerations
- According to the evidence from 1, LMWH should be avoided 12 hours before manipulation of an epidural or spinal catheter and can be administered 2 hours after an epidural catheter is removed.
- The American Society of Clinical Oncology clinical practice guideline update 1 also recommends that prophylactic doses of once-daily LMWH should not be administered within 10 to 12 hours before the procedure/instrumentation (including epidural catheter removal).
- Similarly, the AUA best practice statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery 1 suggests that Enoxaparin should be avoided/held for 24 hours BEFORE planned manipulation and should be resumed no earlier than 2 hours FOLLOWING manipulation.
- The guidelines for perioperative care for pancreaticoduodenectomy: enhanced recovery after surgery (ERAS) society recommendations 1 recommend that the catheter be inserted 12 h after a dose of LMWH, and removed 12 h after administration of LMWH.
- The most recent update from the American Society of Clinical Oncology 1 recommends that the first prophylactic LMWH dose should be administered no sooner than 4 hours after needle/catheter placement, and neuraxial puncture/catheter manipulation or removal should not occur within the first 12 hours after LMWH administration.
Administration Guidelines
- The dose of enoxaparin for prophylaxis is typically 40 mg once daily, as recommended by 1 and 1.
- It is essential to assess renal function before initiating enoxaparin, as patients with poor renal function are at greater risk for complications from bleeding, as noted in 1.
- The guidelines emphasize the importance of weighing the risks of bleeding against the benefits of prophylaxis in determining the timing of initiation of DVT pharmacologic prophylaxis in combination with mechanical prophylaxis, as stated in 1.
From the FDA Drug Label
To reduce the potential risk of bleeding associated with the concurrent use of enoxaparin sodium injection and epidural or spinal anesthesia/analgesia or spinal puncture, consider the pharmacokinetic profile of enoxaparin sodium injection [see Clinical Pharmacology ( 12. 3)] . Placement or removal of an epidural catheter or lumbar puncture is best performed when the anticoagulant effect of enoxaparin sodium injection is low; however, the exact timing to reach a sufficiently low anticoagulant effect in each patient is not known Placement or removal of a catheter should be delayed for at least 12 hours after administration of lower doses (30 mg once or twice daily or 40 mg once daily) of enoxaparin sodium injection and at least 24 hours after the administration of higher doses (0.75 mg/kg twice daily, 1 mg/kg twice daily, or 1. 5 mg/kg once daily) of enoxaparin sodium injection.
The waiting period after enoxaparin (Lovenox) administration before an epidural can be safely performed is:
- At least 12 hours for lower doses (30 mg once or twice daily or 40 mg once daily)
- At least 24 hours for higher doses (0.75 mg/kg twice daily, 1 mg/kg twice daily, or 1.5 mg/kg once daily) 2
From the Research
Waiting Period for Epidural after Enoxaparin Administration
The waiting period after enoxaparin administration before an epidural can be safely performed is a critical consideration to minimize the risk of bleeding complications.
- According to 3, enoxaparin administration within 24 hours of caesarean section appears to be reasonable, regardless of epidural anesthesia, with no cases of spinal epidural hematoma reported.
- However, 4 recommends avoiding the use of enoxaparin in conjunction with an indwelling epidural catheter, as one patient developed an epidural hematoma in their study.
- The study 5 suggests that the anticoagulant effect of enoxaparin is more pronounced when administered twice-daily compared to once-daily, which may impact the timing of epidural catheter removal.
- In terms of specific waiting periods, 6 mentions the importance of withholding enoxaparin for a specific period before performing an epidural blood patch, but does not provide a clear guideline for the waiting period.
Factors Influencing Waiting Period
Several factors may influence the waiting period, including:
- The dosage and frequency of enoxaparin administration, as highlighted in 5
- The presence of other bleeding risk factors, such as concomitant use of other anticoagulants or antiplatelet agents
- The type of surgical procedure and the patient's individual risk profile, as discussed in 4 and 7
Clinical Considerations
When determining the waiting period for epidural placement after enoxaparin administration, clinicians should consider the patient's individual risk factors, the type of surgical procedure, and the dosage and frequency of enoxaparin administration, as well as the potential for bleeding complications, as reported in 3, 4, and 5.